Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2003
05/28/2003EP0814833B1 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
05/28/2003EP0814828B1 Method of preparation a therapeutic agent for the regeneration of oligodendrocytes
05/28/2003EP0788509B1 Therapeutic peptide derivatives
05/28/2003EP0788360B1 Boronic ester and acid compounds, synthesis and uses
05/28/2003EP0786995B1 Use of 5-(tetradecyloxy)-2-furan carboxylic acid for treating alzheimer's disease or psychosis
05/28/2003EP0783314B1 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards
05/28/2003EP0748215B1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
05/28/2003CN1420929A Non-endogenous, constitutively activated known G protein-coupled receptors
05/28/2003CN1420926A Anti-angiogenic proteins and fragments and methods of use thereof
05/28/2003CN1420924A Recombinant human alpha-L-iduronidase, method for producing and purifying same and method for treating disorders including deficiency thereof
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420867A Method for synthesis of perindopril and its pharmaceutically acceptable salts
05/28/2003CN1420797A Method for improvement of islet signaling in diabetes mellitus and for its prevention
05/28/2003CN1420793A Absorbents for dilated cardiomyopathy
05/28/2003CN1420789A Compound for targeting
05/28/2003CN1420788A Improved treatment of neovascularization
05/28/2003CN1420786A Treatment of fungal infections with beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies
05/28/2003CN1420783A Compositions and methods for tumor-targeted delivery of effector molecules
05/28/2003CN1420770A Method of delivery of cetyl myristoleate
05/28/2003CN1420768A Combination product comprising non-steroidal antiandrogen and EGFR tyrosine kinase inhibitor
05/28/2003CN1420759A Slimming composition contg. substance inducing IL-6 production
05/28/2003CN1420723A Compositions and methods for L-nucleosides, and their analogs
05/28/2003CN1420358A Use of chemotaxin-oid factor-1 in inflammatory damage of organs
05/28/2003CN1420125A Trichina antigen gene Ts 87 and use thereof
05/28/2003CN1419936A Blood substitute of hemoglobin microcapsule and preparing method thereof
05/28/2003CN1109558C Stabilized pharmaceutical peptide compositions
05/28/2003CN1109557C Cetroretix lyophilisate and process for preparation thereof
05/27/2003US6570061 Generating transgenic animal; obtain animal blastocyst, transform with expression vector coding immunoglobulin, propagate blastocyst and recover trangenic animal
05/27/2003US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
05/27/2003US6570006 Bacterial gene and method of treating a gram negative bacterial infection
05/27/2003US6570002 Inhibitor of programmed cell death
05/27/2003US6570000 Nucleotide sequence coding monoclonal antibody for use in the treatment of viral diseases
05/27/2003US6569998 Synthetic glycosulfopeptides and methods of synthesis thereof
05/27/2003US6569997 Antibody specific for H4-1BB
05/27/2003US6569996 Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequence
05/27/2003US6569995 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
05/27/2003US6569992 Protein for use in the treatment of immunological, liver, reproductive and infectious disorders
05/27/2003US6569876 Method and structure for inhibiting activity of serine elastases
05/27/2003US6569854 Streptogramin derivatives, their preparation and compositions containing them
05/27/2003US6569851 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
05/27/2003US6569847 Inhibitors of cathepsins for treating muscular dystrophy, osteoporosis, rheumatoid arthritis, neuronal or cardiac ischaemia, allergy, or Chagas disease
05/27/2003US6569835 Hypolipidemics; treating obesity and disorders of lipid metabolism
05/27/2003US6569834 Elucidation and synthesis of antineoplastic tetrapeptide w-aminoalkyl-amides
05/27/2003US6569833 Given amino acid sequence; useful treating hyperproliferative disorders and in drug screening and drug design
05/27/2003US6569832 Use of a glucagon like peptide-1 (GLP-1) agonist
05/27/2003US6569831 Recombinant lactoferrin, methods of production from plants and uses
05/27/2003US6569688 Intravascular apparatus method
05/27/2003US6569679 Recombinant viral vector capable of expressing a gene product that activates a non-cytotoxic compound into a toxic product; use in treatment of viral diseases, cancer, genetic diseases
05/27/2003US6569677 Viral genome mutations involving the recognition and binding of natural cell receptors for adenoviruses; use in human gene therapy applications
05/27/2003US6569667 Useful as modulating agents in regulating cellular growth, proliferation, differentiation, or migration
05/27/2003US6569666 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
05/27/2003US6569665 Genetic engineering; enzymatic inhibitor screening; use of calpain inhibitors in treatment of neurodegenerative disease
05/27/2003US6569664 Tumor necrosis factor (TNF); enzyme purification and characterization; regulation of TNF for use in treatment of inflammatory diseases and conditions
05/27/2003US6569661 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
05/27/2003US6569660 Human DNase
05/27/2003US6569655 For use in therapeutics, diagnostics, and as research tools
05/27/2003US6569645 IL-17 homologous polypeptides and therapeutic uses thereof
05/27/2003US6569642 TNF-Related Apoptosis-Inducing Ligand (TRAIL); isolated DNA probe which hybridizes to nucleic acid of given sequence; use in purifying cells, inhibiting biological activities or as immunogens to produce antibodies
05/27/2003US6569622 Nucleic acids encoding a protein conferring an inducible resistance to glycopeptide, particularly in gram-positive bacteria
05/27/2003US6569483 Dietetic food composition and dietetic method using such composition
05/27/2003US6569464 Antifertility agent comprises coelomic fluid extract which is obtained from an Indian earthworm, Pheretima posthuma, belonging to the phylum, Annelida
05/27/2003US6569463 Encapsulation coat includes different combinations of pharmaceutical active ingredients, hydrophilic and lipophilic surfactants, and triglycerides
05/27/2003US6569457 Enteric coated pharmaceutical tablet and method of manufacturing
05/27/2003US6569456 Angiotensin converting enzyme (ACE) inhibitor; controlled release diltiazem in the core in combination with a rapid release ACE inhibitor, or diuretic, in an external coat; pharmacokinetics; easier to swallow; treating hypertension
05/27/2003US6569443 Topical treatment or prevention of ocular infections
05/27/2003US6569437 Skin disorders
05/27/2003US6569434 Vascular endothelial cell growth factor C subunit
05/27/2003US6569433 Compounds and methods for the diagnosis and treatment of B. microti infection
05/27/2003US6569431 Polypeptide for use in the treatment of autoimmune disease and multiple sclerosis
05/27/2003US6569430 Antibodies to the antigen Campath-1
05/27/2003US6569429 Isolated polypeptide comprising the amino acid residues 1 to 344 of (SEQ ID NO: 2); systemic lupus erythematosus; pulmonary disease or disorder
05/27/2003US6569428 For regulating angiogenesis; nucleic acid encoding an endothelial cell mitogen and endothelial cell progenitors, where the EC progenitors are CD34+, Flk-1+, and tie-2+
05/27/2003US6569420 Human interferon-ε: a type I interferon
05/27/2003US6569419 Methods for promoting production of myelin by Schwann cells
05/27/2003US6569416 Compositions containing synthetic soil-extract materials and medicaments based thereon
05/27/2003US6569406 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
05/27/2003US6569172 Method, instruments, and kit for autologous transplantation
05/27/2003US6569152 Sustained release delivery systems for solutes
05/27/2003CA2321829C Topical composition containing human epidermal growth factor
05/27/2003CA2274241C A process for purifying apolipoprotein a or apolipoprotein e from human plasma
05/27/2003CA2273855C Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof
05/27/2003CA2199747C 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof
05/27/2003CA2176229C Improved interferon polymer conjugates
05/27/2003CA2158455C Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide and their uses in vaccines and disease treatments
05/27/2003CA2140866C Use of inhibitors of fatty acid synthesis for treating cancer
05/27/2003CA2031430C Process for refolding recombinantly produced tgf-.beta.-like proteins
05/27/2003CA2024309C Pharmaceutical compositions comprising modified and unmodified plasminogen activators and uses thereof
05/27/2003CA1341429C Hirudin variants, their use and processes for obtaining them
05/22/2003WO2003042700A2 Breast cancer associated polypeptide
05/22/2003WO2003042402A2 Agents that modulate immune cell activation and methods of use thereof
05/22/2003WO2003042399A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
05/22/2003WO2003042397A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003WO2003042387A1 Novel hair keratin-associated proteins
05/22/2003WO2003042384A1 Inducer for differentiation of embryo stem cells into ectodermal cells, method of obtaining the same and use thereof
05/22/2003WO2003042360A2 Antisense modulation of inhibitor-kappa b-r expression
05/22/2003WO2003042359A2 Histamine receptor h3 polynucleotides
05/22/2003WO2003042358A2 Methods of using 48149, a human aminopeptidase family member
05/22/2003WO2003042357A2 Enzymes
05/22/2003WO2003042354A2 Abrogen polypeptides, nucleic acids encoding them and methods for using them to inhibit angiogenesis
05/22/2003WO2003042344A2 Apo2 ligand/trail formulations
1 ... 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 ... 3163